View in EDS HTML Full Text PDF Full Text

A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.

Saved in:
Bibliographic Details
Title: A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.
Authors: Johnson SM; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. Steven.Johnson@unchealth.unc.edu., Haberberger J; Foundation Medicine, Inc, Cambridge, MA, USA., Galeotti J; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Ramkissoon L; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Coombs CC; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; UC Irvine, 1001 Health Sciences Road, Irvine, CA, 92697, USA., Richardson DR; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Foster MC; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Novartis Pharmaceuticals, Cambridge, MA, 02139, USA., Duncan D; Foundation Medicine, Inc, Cambridge, MA, USA.; GRAIL, Inc., 4001 E NC 54 Hwy Assembly Suite 1100, Durham, NC, 27709, USA., Zeidner JF; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Ferguson NL; Foundation Medicine, Inc, Cambridge, MA, USA., Montgomery ND; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Tempus Labs, Inc., 25 Alexandria Way, Durham, NC, 27703, USA.
Source: Blood cancer journal [Blood Cancer J] 2023 Jun 26; Vol. 13 (1), pp. 96. Date of Electronic Publication: 2023 Jun 26.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37365170
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Johnson+SM%22">Johnson SM</searchLink>; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. Steven.Johnson@unchealth.unc.edu.<br /><searchLink fieldCode="AU" term="%22Haberberger+J%22">Haberberger J</searchLink>; Foundation Medicine, Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Galeotti+J%22">Galeotti J</searchLink>; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ramkissoon+L%22">Ramkissoon L</searchLink>; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Coombs+CC%22">Coombs CC</searchLink>; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; UC Irvine, 1001 Health Sciences Road, Irvine, CA, 92697, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+DR%22">Richardson DR</searchLink>; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Foster+MC%22">Foster MC</searchLink>; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Novartis Pharmaceuticals, Cambridge, MA, 02139, USA.<br /><searchLink fieldCode="AU" term="%22Duncan+D%22">Duncan D</searchLink>; Foundation Medicine, Inc, Cambridge, MA, USA.; GRAIL, Inc., 4001 E NC 54 Hwy Assembly Suite 1100, Durham, NC, 27709, USA.<br /><searchLink fieldCode="AU" term="%22Zeidner+JF%22">Zeidner JF</searchLink>; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ferguson+NL%22">Ferguson NL</searchLink>; Foundation Medicine, Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Montgomery+ND%22">Montgomery ND</searchLink>; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Tempus Labs, Inc., 25 Alexandria Way, Durham, NC, 27703, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2023 Jun 26; Vol. 13 (1), pp. 96. <i>Date of Electronic Publication: </i>2023 Jun 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37365170
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-023-00876-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 96
    Titles:
      – TitleFull: A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Johnson SM
      – PersonEntity:
          Name:
            NameFull: Haberberger J
      – PersonEntity:
          Name:
            NameFull: Galeotti J
      – PersonEntity:
          Name:
            NameFull: Ramkissoon L
      – PersonEntity:
          Name:
            NameFull: Coombs CC
      – PersonEntity:
          Name:
            NameFull: Richardson DR
      – PersonEntity:
          Name:
            NameFull: Foster MC
      – PersonEntity:
          Name:
            NameFull: Duncan D
      – PersonEntity:
          Name:
            NameFull: Zeidner JF
      – PersonEntity:
          Name:
            NameFull: Ferguson NL
      – PersonEntity:
          Name:
            NameFull: Montgomery ND
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 06
              Text: 2023 Jun 26
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1